Case report: Treatment of metastatic dedifferentiated chondrosarcoma with pembrolizumab yields sustained complete response

Dedifferentiated chondrosarcomas (DDCS) are aggressive tumors with poor outcomes. Treatment of localized DDCS is primarily surgical, though most patients present with unresectable or metastatic disease. Systemic treatment options for advanced DDCS are limited, and the benefits of chemotherapy in thi...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Amisha Singh, Steven W. Thorpe, Morgan Darrow, Janai R. Carr-Ascher
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Frontiers Media S.A. 2022-11-01
Schriftenreihe:	Frontiers in Oncology
Schlagworte:	case report pembrolizumab immunotherapy outcomes dedifferentiated chondrosarcoma (DDCS) chondrosarcoma
Online-Zugang:	https://www.frontiersin.org/articles/10.3389/fonc.2022.991724/full
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!